Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neocor Therapeutics
La Ciotat, Provence-Alpes-Côte d'Azur, Franceneocor.fr ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Preclinical
01
Overview
Neocor Therapeutics develops novel gene therapies aimed at regenerating cardiomyocytes and preventing cardiac fibrosis to treat ischemic and rare genetic heart diseases. The company’s technology remains in the preclinical research phase with no reported human clinical results yet[1].
- Therapeutic areas
- Cardiovascular
- Modalities
- Gene therapy
- Industry
- Biotech
02
Partnerships
Not specified; mentions support from partners but does not list names[1]
Beyond the preview
Go deeper on Neocor Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neocor Therapeutics.